Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on December 8, 2009, reporting a material definitive agreement. Specifically, the company entered into a Fourth Amendment to an existing operating lease with BioMed Realty Trust, Inc. (through its affiliate BMR-Landmark at Eastview LLC) for its corporate headquarters and research and development facilities. This amendment significantly expands the company's leased space by adding approximately 131,000 square feet of newly constructed laboratory and office space. This expansion, located in the Town of Greenburgh, Westchester County, New York, is a key indicator of Regeneron's growth and commitment to enhancing its research and development capabilities. Investors should note this as a positive development reflecting the company's strategic expansion and investment in its operational infrastructure.
Key Highlights
- 1Regeneron Pharmaceuticals entered into a Fourth Amendment to an operating lease agreement on December 3, 2009.
- 2The lease is with BioMed Realty Trust, Inc. (through its affiliate BMR-Landmark at Eastview LLC).
- 3The amendment concerns the company's corporate headquarters and research and development facilities.
- 4Approximately 131,000 square feet of newly constructed laboratory and office space will be added to the leased premises.
- 5The expansion is located in the Town of Greenburgh, Westchester County, New York.
- 6This filing indicates a material definitive agreement, signaling potential growth and increased operational capacity for Regeneron.